BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12649417)

  • 21. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases.
    Harvey CJ; Blomley MJ; Eckersley RJ; Heckemann RA; Butler-Barnes J; Cosgrove DO
    Lancet; 2000 Mar; 355(9206):807-8. PubMed ID: 10711932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between tissue harmonic imaging and liver-specific late-phase contrast-enhanced pulse-inversion imaging in the detection of hepatocellular carcinoma and liver metastasis.
    Rabenandrasana HA; Furukawa A; Furuichi K; Yamasaki M; Takahashi M; Murata K
    Radiat Med; 2004; 22(2):90-7. PubMed ID: 15176603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
    Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
    Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A.
    Dietrich CF; Ignee A; Trojan J; Fellbaum C; Schuessler G
    Gut; 2004 Mar; 53(3):401-5. PubMed ID: 14960524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasonography in diagnosing liver metastases.
    Janica JR; Lebkowska U; Ustymowicz A; Augustynowicz A; Kamocki Z; Werel D; Polaków J; Kedra B; Pepinski W
    Med Sci Monit; 2007 May; 13 Suppl 1():111-5. PubMed ID: 17507895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer.
    Piscaglia F; Corradi F; Mancini M; Giangregorio F; Tamberi S; Ugolini G; Cola B; Bazzocchi A; Righini R; Pini P; Fornari F; Bolondi L
    BMC Cancer; 2007 Sep; 7():171. PubMed ID: 17767722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience.
    Solbiati L; Goldberg SN; Ierace T; Dellanoce M; Livraghi T; Gazelle GS
    Radiology; 1999 Jun; 211(3):643-9. PubMed ID: 10352586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
    Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
    AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver metastases in cancer: detection with contrast-enhanced ultrasonography.
    Hohmann J; Albrecht T; Oldenburg A; Skrok J; Wolf KJ
    Abdom Imaging; 2004; 29(6):669-81. PubMed ID: 15185032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases.
    Del Frate C; Zuiani C; Londero V; Como G; Bazzocchi M; Mortele K; Ros PR
    AJR Am J Roentgenol; 2003 May; 180(5):1339-46. PubMed ID: 12704048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
    Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound.
    Yarmenitis SD; Karantanas A; Bakantaki A; Papantoniou Y; Gourtsoyiannis N
    Dig Dis; 2007; 25(1):86-93. PubMed ID: 17384513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.
    Lee JM; Youk JH; Lee YH; Kim YK; Kim CS; Li CA
    Korean J Radiol; 2003; 4(2):124-9. PubMed ID: 12845308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning.
    Silverman PM; O'Malley J; Tefft MC; Cooper C; Zeman RK
    AJR Am J Roentgenol; 1995 Mar; 164(3):619-23. PubMed ID: 7863882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
    Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
    AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
    Oldenburg A; Albrecht T
    Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.